With a market cap of $174.7 billion, Abbott Laboratories (ABT) is a diversified healthcare company that develops medical devices, diagnostics, nutrition products and pharmaceuticals. The Abbott Park, Illinois-based company operates in more than 160 countries and serves more than 2 billion people globally.
The company is expected to unveil its fiscal Q3 2026 results on Wednesday, Oct. 21, before the market opens. Ahead of the event, analysts forecast ABT to post an adjusted EPS of $1.43, a rise of 10% from $1.30 in the same quarter last year. It has surpassed or met Wall Street's bottom-line projections in the past four quarters.